Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Programme
Postgraduate Teaching
Industry Programme
List of Supporters & Exhibitors
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Session
IBD (Posters)
HEAD-TO-HEAD PHARMACOKINETIC ANALYSIS OF INFLIXIMAB MONO- VS COMBINATION THERAPY IN PAEDIATRIC CROHN’S DISEASE
HOW IS THE CLINICAL COURSE AND DRUG TOXICITY IN LATE-ONSET IBD PATIENTS?
THE PERSISTENCE OF ANTI-SPIKE ANTIBODIES FOLLOWING TWO SARS-COV-2 VACCINES IN PATIENTS WITH INFLAMMATORY BOWEL- AND JOINT DISEASES ON IMMUNOSUPPRESSIVE THERAPY COMPARED TO HEALTHY CONTROLS – A PROSPECTIVE COHORT STUDY
SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)
SMOKING AND COLITIS-ASSOCIATED COLORECTAL NEOPLASIA: EXPLORING THE RELATIONSHIP
MUCOSAL AND PLASMA METABOLOMES IN NEW-ONSET PAEDIATRIC INFLAMMATORY BOWEL DISEASE: CORRELATIONS WITH DISEASE CHARACTERISTICS AND PLASMA INFLAMMATION PROTEIN MARKERS
USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE: RESULTS UP TO WEEK 104 OF THE STARDUST TRIAL
RELATIONSHIP BETWEEN INTESTINAL ULTRASOUND, FECAL CALPROTECTIN AND HARVEY BRADSHAW INDEX IN THE ASSESSMENT OF INFLAMMATORY ACTIVITY IN CROHN'S DISEASE
HIDRADENITIS SUPPURATIVA AND INFLAMMATORY BOWEL DISEASE IN A CASE-CONTROL STUDY
EXCLUSIVE ENTERAL NUTRITION DRIVES PROTECTIVE MICROBIOME MODULATION IN PEDIATRIC CROHN’S DISEASE
ENDOSCOPIC FEATURES OF NON-IBD COLITIS
METAGENOMIC ANALYSIS OF A SIGNATURE GUT MICROBIOME BIOMARKER IN CROHN'S DISEASE ACROSS FIVE POPULATIONS
ANTI-INFLAMMATORY AND BARRIER STABILIZING EFFECTS OF A HERBAL COMBINATION MEDICINE OF MYRRH, COFFEE CHARCOAL AND CHAMOMILE FLOWER EXTRACT IN A MULTI-COMPONENT CELL MODEL OF THE INFLAMED INTESTINAL MUCOSA
DEFINITIVE SURGICAL MANAGEMENT OF PERIANAL FISTULAS IN ADULTS WITH CROHN’S DISEASE: A CROSS-SECTIONAL ANALYSIS OF LOCAL PRACTICE IN AUSTRALIA AND NEW ZEALAND
EFFECTIVENESS AND SAFETY OF SWITCHING FROM ADALIMUMAB REFERENCE TO BIOSIMILAR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: THE ADA-SWITCH STUDY
ENDOSCOPIC SCORES AS PREDICTORS OF TREATMENT FAILURE IN ULCERATIVE COLITIS
EXPLORATORY ANALYSIS OF FILGOTINIB SAFETY DATA IN A SELECTED POPULATION OF PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM FINCH 1–4 AND DARWIN 1–3 STUDIES IN PERSPECTIVE TO INTEGRATED ULCERATIVE COLITIS SAFETY DATA
INFLUENCE OF DIABETES MELLITUS ON INFLAMMATORY BOWEL DISEASE COURSE AND TREATMENT OUTCOMES.A SYSTEMATIC REVIEW WITH META-ANALYSIS
LOW FREQUENCIES OF CIRCULATING INHIBITORY TIGIT+CD38+ EFFECTOR T CELLS IDENTIFY AN IMMUNOLOGICALLY DISTINCT SUBGROUP OF PEDIATRIC PATIENTS WITH SEVERE CROHN’S DISEASE
INCREASE IN CIRCULATING T AND B LYMPHOCYTE SUBSETS AFTER TREATMENT WITH THE POTENT, SELECTIVE, ORAL, SMALL MOLECULE ALPHA4BETA-7 INHIBITOR MORF-057 IN HEALTHY SUBJECTS
Item 201 - 220 / 612
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Chat with us
, powered by
LiveChat